Myriad Genetics Inc (NASDAQ:MYGN)

21.37
Delayed Data
As of May 24
 -0.33 / -1.52%
Today’s Change
18.98
Today|||52-Week Range
36.95
-22.57%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Myriad Genetics Inc have a median target of 22.00, with a high estimate of 27.00 and a low estimate of 18.00. The median estimate represents a +2.95% increase from the last price of 21.37.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Hold stock in Myriad Genetics Inc. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.03
Sales
$172.1M
Reporting Date
Aug 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 195.83%
 
 
 
 
 
 
Growthannually 375.00%
 
 
 
 
 
 

Sales

Growthquarterly 4.38%
 
 
 
 
 
 
Growthannually -0.54%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.